Literature DB >> 25303029

Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal.

Alexandra L Jenkins1, Linda M Morgan, Jacqueline Bishop, Elena Jovanovski, Vladimir Vuksan.   

Abstract

BACKGROUND/
OBJECTIVE: Addition of viscous fiber to foods has been shown to significantly reduce postprandial glucose excursions. However, palatability issues and the variability in effectiveness due to different methods of administration in food limits it use. This study explores the effectiveness of a viscous fiber blend (VFB) in lowering postprandial glycemia using different methods of incorporation.
METHODS: Two acute, randomized, controlled studies were undertaken: Study 1: Twelve healthy individuals (mean ± SD, age: 36 ± 13 years, body mass index [BMI]: 27 ± 4 kg/m(2)) consumed 8 different breakfasts. All meals consisted of 50 g of available carbohydrate from white bread (WB) and 10 g margarine. Zero, 1, 2, or 4 g of the VFB was baked into WB or mixed with the margarine. Study 2: Thirteen healthy individuals (mean ± SD, age: 39 ± 17 years, BMI: 25 ± 5 kg/m(2)) consumed 6 test meals, consisting of 50 g of available carbohydrate from WB. Six capsules containing either cornstarch or VFB were taken at 4 different time points during the glucose tolerance test. After obtaining a fasting finger-prick blood sample, volunteers consumed the test meal over a 10-minute period. Additional blood samples were taken at 15, 30, 45, 60, 90, and 120 minutes from the start of the meal. For study 2, an additional fasting sample was obtained at -30 minutes.
RESULTS: Study 1: Irrespective of VFB dose, glucose levels were lower at 30 and 45 minutes when VFB was mixed into the margarine compared to the control (p < 0.05). Incremental areas under the curve were significantly lower compared to control when 4 g of VFB was mixed into the margarine. Study 2: There was no effect of the VFB on postprandial glucose levels when administered in capsules.
CONCLUSION: Incorporation of VFB into margarine was more effective in lowering postprandial glycemia than when the VFB was baked into bread and no effect when given in capsules.

Entities:  

Keywords:  clinical trials; diabetes; preventative nutrition and chronic disease; supplements and functional foods; type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25303029     DOI: 10.1080/07315724.2014.905762

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  5 in total

1.  Co-administration of a konjac-based fibre blend and American ginseng (Panax quinquefolius L.) on glycaemic control and serum lipids in type 2 diabetes: a randomized controlled, cross-over clinical trial.

Authors:  Alexandra L Jenkins; Linda M Morgan; Jacqueline Bishop; Elena Jovanovski; David J A Jenkins; Vladimir Vuksan
Journal:  Eur J Nutr       Date:  2017-07-07       Impact factor: 5.614

2.  An Optimized, Slowly Digested Savory Cluster Reduced Postprandial Glucose and Insulin Responses in Healthy Human Subjects.

Authors:  Thomas M S Wolever; Alexandra L Jenkins; Jun Yang; Mark Nisbet; Jodee Johnson; YiFang Chu; Yang Pan
Journal:  Curr Dev Nutr       Date:  2019-01-17

3.  Male grower pigs fed cereal soluble dietary fibres display biphasic glucose response and delayed glycaemic response after an oral glucose tolerance test.

Authors:  Anton M Pluschke; Barbara A Williams; Dagong Zhang; Stephen T Anderson; Eugeni Roura; Michael J Gidley
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

4.  Influence of high fat and different types of carbohydrate diet on energy metabolism in growing mice.

Authors:  Nana Chung; Kiwon Lim
Journal:  J Exerc Nutrition Biochem       Date:  2019-09-30

5.  The effect of swimming exercise and powdered-Salicornia herbacea L. ingestion on glucose metabolism in STZ-induced diabetic rats.

Authors:  Se Sil Lee; Hyobin Seo; Sungpil Ryu; Tae-Dong Kwon
Journal:  J Exerc Nutrition Biochem       Date:  2015-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.